Pharmacia & Upjohn consumer health sales down 17.8% to $153.2 mil. in first quarter.
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA & UPJOHN CONSUMER HEALTH FIRST QUARTER SALES DOWN 17.8% to $153.2 mil. First quarter 1996 consumer health care sales were up due to "significant" prestocking of Rogaine hair regrowth treatment and Nicorette smoking cessation gum in preparation of their OTC launches in the second quarter last year, Pharmacia & Upjohn said April 29. P&U manufactures Nicorette and markets it abroad; the product is marketed by SmithKline Beecham in the U.S.You may also be interested in...
People In Brief
Perrigo promotes in pricing, planning
In Brief
Combe sells most of its OTC brands
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports